CAELYX conc perf 20 mg/10ml amp 10 ml

7680542730103 CH-54273 L01DB01 07.16.1.

Reimbursement limitations:

CAELYX3

Traitement du sarcome de Kaposi associé au SIDA chez les patients ayant un taux de …

CAELYX conc perf 20 mg/10ml amp 10 ml
CAELYX conc perf 20 mg/10ml amp 10 ml
1 / 2
google

Details

Product number
5427301
CPT
-
Packaging group
20 mg / 10
Unit
ml
Composition
doxorubicini hydrochloridum 2 mg, N-(carbonyl-methoxypolyethylenglycoli 2000)-1,2-distearoyl-sn-glycero-3-phosphoethanolaminum natricum, phosphatidylcholinum ex soja hydrogenatum, cholesterolum, ammonii sulfas, saccharum, histidinum, acidum hydrochloridum aut natrii hydroxidum, aqua ad iniectabile q.s. ad suspensionem pro 1 ml corresp. natrium 0.054 mg.

Articles (1)

Caelyx, Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
20 mg / 10
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
16/11/2023
Professional SmPC
Français
16/11/2023
Professional SmPC
Italien
16/11/2023

Detailed composition

Substance Quantity Type Category
(N/A)
2.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
0.054 MG Substance HBESI

Reimbursement information

Public price
CHF 180.45
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 15/03/1999

Authorization holder

Baxter AG

8152 Opfikon

Authorization information

Swissmedic authorization number
54273
Drug name
Caelyx, Konzentrat zur Herstellung einer Infusionslösung
Galenic form
KOINF
ATC Code
L01DB01
Authorization status
Z
Dispensation category
A
First authorization
24/12/1997
Authorization expiration date
31/12/9999
IT number
07.16.1.
Domain
Human medicine
Field of application
Zytostatikum

Packaging details

Description (FR)
CAELYX conc perf 20 mg/10ml amp 10 ml
Description (DE)
CAELYX Inf Konz 20 mg/10ml Amp 10 ml
Market launch
24/12/1997
Narcotic (BTM)
No

Available generics

Doxorubicin Accord, Injektionslösung
CHF 28.45
View
Doxorubicin Accord, Injektionslösung
CHF 40.45
View
Doxorubicin Accord, Injektionslösung
CHF 76.55
View
Doxorubicin Accord, Injektionslösung
CHF 136.70
View
Doxorubicin Accord, Injektionslösung
CHF 257.00
View
Doxorubicin Accord liposomal, Konzentrat zur Herstellung einer Infusionsdispersion
CHF 180.45
View
Doxorubicin Accord liposomal, Konzentrat zur Herstellung einer Infusionsdispersion
CHF 339.90
View
Doxorubicin Sandoz eco, Konzentrat zur Herstellung einer Infusionslösung
CHF 28.50
View
Doxorubicin Sandoz eco, Konzentrat zur Herstellung einer Infusionslösung
CHF 76.55
View
Doxorubicin Sandoz eco, Konzentrat zur Herstellung einer Infusionslösung
CHF 136.70
View

Other packaging sizes